Effect of dihydralazine on the fluidity of erythrocyte membranes
Related Experiment Video
Updated: Jun 19, 2026

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
M Maliszewska-Mazur1, A F Sikorski, A Jezierski
1University of Wrocław, Faculty of Chemistry, Wrocław, Poland.
Abstract:
Dihydralazine, a drug used in the treatment of chronic hypertension was found to affect the mobility of fatty acid hydrocarbon chains followed by spin-labelling technique with the use of 5-, 12- and 16-doxylstearate. The effect of this drug on the membrane bilayer properties may result either from the reduction of the number of double bonds in fatty acid hydrocarbon chains, as was shown by the changes of d1/d and order parameters in the region of C(12) or from direct interactions of the drug with the polar head group region of the phospholipids as was shown by changes in the distance between nitroxyl groups without changes of the order parameter in the region of C(5).
Related Concept Videos
Heart Failure Drugs: Diuretics
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Thiazide-Class Diuretics
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

